CJC-1295 With DAC + Ipamorelin + GHRP-2 Blend – Product Information
The blend of CJC-1295 with DAC, Ipamorelin, and GHRP-2 combines three synthetic peptides with the aim of enhancing the release of growth hormone (GH) and potentially amplifying their individual effects. Each peptide within the blend has unique properties that contribute to their potential synergistic interactions.
When combined, the CJC-1295 with DAC, Ipamorelin, and GHRP-2 blend aims to leverage the potential synergistic effects of the individual peptides on GH release. CJC-1295 with DAC provides sustained release of GH, while Ipamorelin and GHRP-2 offer more immediate and short-lived potential boosts to GH levels. If research is to be proven, this combination may result in a pulsatile release of GH, potentially leading to enhanced anabolic effects, muscle growth, improved body composition, and other physiological benefits.
However, it is important to note that the specific interactions and combined effects of these peptides in a blend are still an area of scientific research. Purerawz sells CJC-1295 With DAC + Ipamorelin + GHRP-2 Blend for research purposes only.
- CJC-1295 With DAC + Ipamorelin + GHRP-2 Blend consists of three compounds: CJC-1295 With DAC, Ipamorelin, and GHRP-2.
- This peptide blend contains 2mg CJC-1295 With DAC, 2mg Ipamorelin, and 2mg GHRP-2, totaling 6mg.
CJC-1295 is a synthetic GHRH (growth hormone-releasing hormone) analog made up of 30 amino acids. It has been found to be highly effective in research studies for the increase of growth hormone secretion and IGF-1 without negatively affecting the pulsatility of GH secretion.
|CJC – 1295 DAC Peptide|
|Molar Mass||3367.954 g·mol−1|
|IUPAC Name||CJC 1295 (DAC-GRF)|
Ipamorelin is a pentapeptide, which displays high GH-releasing potency and efficacy in vitro and in vivo. Ipamorelin is the first GHRP-receptor agonist with a selectivity for GH release similar to that displayed by GHRH. The specificity of ipamorelin makes this compound a very interesting candidate for future clinical development.
|Molar Mass||711.868 g·mol−1|
GHRP-2 is a synthetic agonist of ghrelin, the newly-discovered gut peptide which binds to the growth hormone (GH) secretagogue receptor. Ghrelin has two major effects, stimulating both GH secretion and potentially appetite/meal initiation. GHRP-2 has been extensively studied for its utility as a growth hormone secretagogue and animal studies have shown its potential effect on food intake.
|Molar Mass||817.992 g·mol−1|